MYCOPLASMACHECK
GATC BiotechQuality control of cell lines to improve validity in cell culture research.
Quality control of cell lines to improve validity in cell culture research.
The INTERCEPT Blood System, pathogen reduction system, a proactive approach to TTI risk reduction provides continued protection against TTIs through broad spectrum inactivation of viruses, bacteria, and parasites. INTERCEPT is approved as an alternative to gamma irradiation for prevention of transfusion-associated graft versus host disease (TA-GVHD) in platelet components.